TickerFacts.

Beta Bionics, Inc. (BBNX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$56.22M
Year ended 2025-12-31
-$61.41M
Trailing 12 months to 2026-06-30
2023-12-31: -$32.85M2024-12-31: -$51.67M2025-12-31: -$56.22M-$56.22M
2023-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$56.22Mn/m2026-02-24, From 2025-01-01
2024-12-31-$51.67Mn/m2026-02-24, From 2024-01-01
2023-12-31-$32.85Mn/a2025-03-28, From 2023-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Beta Bionics, Inc. (BBNX)2025-12-31-$56.22Mn/m
NeuroPace Inc (NPCE)2025-12-31-$11.34Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$116.59Mn/m
Pulmonx Corp (LUNG)2025-12-31-$32.83Mn/m
Anika Therapeutics, Inc. (ANIK)2025-12-31$4.36Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$53.22Mn/m
Delcath Systems, Inc. (DCTH)2025-12-31$20.97Mn/m
Iradimed Corp (IRMD)2025-12-31$17.18M-2.5%
TELA Bio, Inc. (TELA)2025-12-31-$28.67Mn/m

Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗